<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01769157</url>
  </required_header>
  <id_info>
    <org_study_id>LC-TH-1101</org_study_id>
    <nct_id>NCT01769157</nct_id>
  </id_info>
  <brief_title>Effects of L-carnitine on Hypothyroidism</brief_title>
  <official_title>Single-center, Randomized, Double-Blinded, Comparative Study of the Effectiveness of L-carnitine in Patients'Fatigue Degree Changing With Hypothyroidism Who Take Levothyroxine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Korea University Anam Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>IlDong Pharmaceutical Co Ltd</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Korea University Anam Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      L-carnitine and thyroid hormone tended to antagonize reciprocally in human body. Urinary
      excretion of L-carnitine decreased in hypothyroid patients, and levothyroxine supplementation
      increased excretion of L-carnitine. The investigators hypothesized that supplying L-carnitine
      to hypothyroid patients with fatigue symptom could improve the quality of life, and fatigue
      score in them. Therefore, the investigators planned to compare the efficacy of L-carnitine
      and placebo in hypothyroid patients who had taken levothyroxine.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fatigue Severity scale</measure>
    <time_frame>baseline and 12 weeks</time_frame>
    <description>Change from Baseline in Fatigue severity scale at 12 weeks (scoring `fatigue severity scale` at baseline and 12 weeks)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Wessely and Powell score</measure>
    <time_frame>baseline and 12 weeks</time_frame>
    <description>Change from Baseline in Wessely and Powell score at 12 weeks (scoring `Wessely and Powell score` at baseline and 12 weeks)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>thyroid function test</measure>
    <time_frame>baseline and 12 weeks</time_frame>
    <description>measure thyroid-stimulating hormone and free T4 at baseline and 12 weeks</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Hypothyroidism</condition>
  <arm_group>
    <arm_group_label>L-carnitine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>L-carnitine 330mg, 3 tablet twice daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo drug, 3 tablet twice daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>L-carnitine</intervention_name>
    <arm_group_label>L-carnitine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of hypothyroidism with fatigue symptom

          -  Currently use of the same amount of levothyroxine over at least six months

          -  Normal serum free T4 level

        Exclusion Criteria:

          -  Current smoker

          -  Serum hemoglobin level of under 12mg/dL

          -  Clinical diagnosis of diabetes mellitus or fasting serum glucose level ≥ 126mg/dL or
             HbA1c level ≥ 6.5%

          -  History of significant heart failure

          -  History of large amount of alcohol consumption

          -  Uncontrolled hypertension (systolic blood pressure ≥ 160 millimeter of mercury (mmHg)
             or diastolic blood pressure ≥ 100 mmHg

          -  pregnant, or planning to be pregnant, or breast feeding women

          -  aspartate aminotransferase (AST) or alanine aminotransferase (ALT) ≥ 2 times of normal
             limit

          -  serum Cr level &gt; 2.0mg/dL
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Korea University Anam Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 10, 2013</study_first_submitted>
  <study_first_submitted_qc>January 15, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 16, 2013</study_first_posted>
  <last_update_submitted>December 2, 2013</last_update_submitted>
  <last_update_submitted_qc>December 2, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 4, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Korea University Anam Hospital</investigator_affiliation>
    <investigator_full_name>Sin Gon Kim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypothyroidism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

